News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
119,222 Results
Type
Article (12163)
Company Profile (22)
Press Release (107037)
Multimedia
Podcasts (16)
Webinars (9)
Section
Business (29753)
Career Advice (248)
Deals (4799)
Drug Delivery (32)
Drug Development (14812)
Employer Resources (26)
FDA (3897)
Job Trends (3064)
News (53940)
Policy (6340)
Tag
2027 Biotech Bay Standard (1)
Academia (698)
Accelerated approval (10)
Adcomms (11)
Allergies (32)
Alliances (8494)
ALS (29)
Alzheimer's disease (649)
Antibody-drug conjugate (ADC) (71)
Approvals (3892)
Artificial intelligence (171)
Autoimmune disease (33)
Automation (11)
Bankruptcy (45)
Best Places to Work (2494)
BIOSECURE Act (5)
Biosimilars (35)
Biotechnology (7)
Bladder cancer (67)
Brain cancer (15)
Breast cancer (255)
Cancer (1631)
Cardiovascular disease (114)
Career advice (222)
Career pathing (12)
CAR-T (71)
CDC (17)
Cell therapy (182)
Cervical cancer (21)
Clinical research (12608)
Collaboration (380)
Company closure (1)
Compensation (48)
Complete response letters (17)
COVID-19 (1001)
CRISPR (23)
C-suite (278)
Cystic fibrosis (26)
Data (1576)
Decentralized trials (1)
Denatured (3)
Depression (26)
Diabetes (125)
Diagnostics (4082)
Digital health (14)
Diversity (3)
Diversity, equity & inclusion (10)
Drug discovery (63)
Drug pricing (72)
Drug shortages (14)
Duchenne muscular dystrophy (52)
Earnings (11302)
Editorial (24)
Employer branding (4)
Employer resources (28)
Events (13135)
Executive appointments (273)
FDA (4626)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (5)
Frontotemporal dementia (4)
Funding (329)
Gene editing (47)
Generative AI (9)
Gene therapy (176)
GLP-1 (265)
Government (1404)
Grass and pollen (1)
Guidances (78)
Healthcare (3353)
HIV (19)
Huntington's disease (14)
IgA nephropathy (28)
Immunology and inflammation (86)
Immuno-oncology (15)
Indications (29)
Infectious disease (1094)
Inflammatory bowel disease (31)
Inflation Reduction Act (4)
Influenza (40)
Intellectual property (49)
Interviews (45)
IPO (2130)
IRA (17)
Job creations (673)
Job search strategy (176)
JPM (12)
Kidney cancer (10)
Labor market (13)
Layoffs (170)
Leadership (9)
Legal (1126)
Liver cancer (27)
Longevity (1)
Lung cancer (210)
Lymphoma (116)
Machine learning (15)
Management (10)
Manufacturing (153)
MASH (52)
Medical device (2606)
Medtech (2617)
Mergers & acquisitions (2859)
Metabolic disorders (332)
Multiple sclerosis (53)
NASH (8)
Neurodegenerative disease (110)
Neuropsychiatric disorders (24)
Neuroscience (935)
NextGen: Class of 2026 (942)
Non-profit (970)
Now hiring (2)
Obesity (168)
Opinion (92)
Ovarian cancer (35)
Pain (37)
Pancreatic cancer (78)
Parkinson's disease (76)
Partnered (6)
Patents (85)
Patient recruitment (97)
Peanut (8)
People (9567)
Pharmaceutical (3)
Pharmacy benefit managers (10)
Phase 1 (3425)
Phase 2 (5547)
Phase 3 (4986)
Pipeline (1222)
Policy (88)
Postmarket research (371)
Preclinical (1306)
Press Release (7)
Prostate cancer (103)
Psychedelics (8)
Radiopharmaceuticals (88)
Rare diseases (216)
Real estate (849)
Recruiting (8)
Regulatory (4982)
Reports (8)
Research institute (672)
Resumes & cover letters (34)
Rett syndrome (4)
RNA editing (5)
RSV (22)
Schizophrenia (24)
Series A (50)
Series B (32)
Service/supplier (1)
Sickle cell disease (28)
Special edition (5)
Spinal muscular atrophy (47)
Sponsored (9)
Startups (591)
Stomach cancer (4)
Supply chain (23)
Tariffs (37)
The Weekly (13)
Vaccines (321)
Venture capital (26)
Weight loss (125)
Women's health (23)
Worklife (2)
Date
Last 7 days (114)
Last 30 days (440)
Last 365 days (6380)
2026 (586)
2025 (6517)
2024 (7086)
2023 (7722)
2022 (10006)
2021 (10652)
2020 (10356)
2019 (7940)
2018 (6180)
2017 (5942)
2016 (5741)
2015 (6222)
2014 (4307)
2013 (3347)
2012 (3808)
2011 (4059)
2010 (3590)
Location
Africa (151)
Alabama (14)
Arizona (56)
Arkansas (3)
Asia (6928)
Australia (1310)
California (2115)
Canada (506)
China (166)
Colorado (70)
Connecticut (86)
Delaware (77)
Europe (17519)
Florida (196)
Georgia (66)
Idaho (5)
Illinois (151)
India (16)
Indiana (88)
Iowa (4)
Japan (99)
Kansas (15)
Kentucky (9)
Louisiana (7)
Maine (24)
Maryland (278)
Massachusetts (1508)
Michigan (61)
Minnesota (66)
Mississippi (1)
Missouri (29)
Nebraska (6)
Nevada (20)
New Hampshire (31)
New Jersey (584)
New Mexico (8)
New York (738)
North Carolina (209)
Northern California (1001)
Ohio (49)
Oklahoma (3)
Oregon (6)
Pennsylvania (447)
Puerto Rico (3)
Rhode Island (8)
South America (172)
South Carolina (3)
Southern California (836)
Tennessee (29)
Texas (523)
United States (7772)
Utah (145)
Virginia (50)
Washington D.C. (17)
Washington State (183)
Wisconsin (59)
119,222 Results for "thrive earlier detection".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
biomodal to Showcase Clinical Research for Earlier Detection of Colorectal Cancer at The Festival of Genomics and Biodata London 2026
January 28, 2026
·
2 min read
Press Releases
biomodal Publishes Study in Nature Communications Medicine Highlighting Breakthrough in Earlier Colorectal Cancer Detection
January 20, 2026
·
3 min read
Press Releases
Earlier Use of Metagenomic (mNGS) Testing Can Reduce Number of Tests Performed and Days to Diagnosis of Meningitis/Encephalitis
January 22, 2026
·
3 min read
BROUGHT TO YOU BY PLIANCY
Webinar: Are We There Yet? Surviving and Thriving in the Never-ending Biotech Downturn
BioSpace sits down with four NextGen companies that are thriving despite a multi-year down period. You will hear about ways they are defying the odds to churn out clinical data that may finally provide the industry with a ladder out. Watch now.
May 21, 2025
·
1 min read
·
BioSpace Insights
Press Releases
PharmaTher Announces KetAImine(TM) - AI Discovery Platform to Expand the Ketamine Portfolio, Enable Earlier Partnering, and Fast-Track 505(b)(2) NDA Filings
Expanding ketamine indications, fortifying IP, enabling earlier partnerships, and accelerating FDA pathways - underpinned by PharmaTher’s Digital Health AI division, leveraging the Company’s FDA-approved ketamine ANDA CMC and KetaVault(TM) data advantage.
October 15, 2025
·
7 min read
Complete response letters
Lack of US Data Stymie Roche’s Earlier-Stage Lymphoma Push for Columvi
Roche and Genentech were unable to sufficiently demonstrate the benefit of using Columvi in an earlier treatment setting for DLBCL in a U.S. population, according to the FDA.
July 21, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Protara Therapeutics Announces Dosing of First Patient in Phase 3 Registrational THRIVE-3 Trial of IV Choline Chloride in Patients on Long-Term Parenteral Support
January 8, 2026
·
7 min read
Press Releases
Legend Biotech to Present CARVYKTI® Data at 2026 Tandem Meetings Reinforcing Growing Evidence Supporting Earlier Use
January 21, 2026
·
28 min read
Press Releases
BioMark Diagnostics Announces Publication of Peer-Reviewed Validation of Machine Learning Models for Lung Cancer Detection in Frontiers in Oncology
Advancing Superior Accuracy in Early Lung Cancer Detection Using Selective Metabolic Pathways and Data Enrichment for Enhanced Diagnostic Capabilities
January 15, 2026
·
4 min read
Press Releases
Roche presents Lunsumio data showing potential across earlier treatment lines in indolent and aggressive lymphomas
December 9, 2025
·
11 min read
1 of 11,923
Next
